These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13418520)

  • 21. [Comparative study of the effects of medical & surgical treatment in patients with chronic obstructive arterial diseases of the lower limbs with special reference to renal function].
    CALIFANO G; TERAMO A; GIORDANO C
    G Ital Chir; 1957 Nov; 13(11):1113-9. PubMed ID: 13512730
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lytic cocktail in the treatment of juvenile chronic obliterating arterial disease].
    NICOLOSI G
    Minerva Med; 1953 Sep; 44(70):497-9. PubMed ID: 13110893
    [No Abstract]   [Full Text] [Related]  

  • 23. [The efficacy of a diet enriched with lipotropic factors, vitamin C and vitamin B complex in patients with chronic hepatitis].
    KHODYKIN AV
    Vopr Pitan; 1958; 17(2):19-29. PubMed ID: 13569937
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral arterial diseases.
    EJRUP B
    Bibl Cardiol; 1958; 8():59-60. PubMed ID: 13596336
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of peripheral arterial diseases by histamine perfusion].
    KULEY M; UNC A
    Turk Tip Cemiy Mecm; 1956 Jul; 22(7):421-6. PubMed ID: 13391980
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tentative interpretation of the mechanism of action of heparin in small dosage by intra-arterial route in various peripheral vascular diseases].
    BUTTO' M; MASETTO I; MENOZZI L
    Riforma Med; 1955 Jan; 69(3):61-5. PubMed ID: 14372779
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peripheral arterial disease: where are we in 2006?].
    Sraieb T; Bougamra S; Ben Romdhane N; Longo S; Manaa J
    Tunis Med; 2007 May; 85(5):361-6. PubMed ID: 17657918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case of ulcerous form of purpuric and pigmented angiodermatitis treated with vitamin P and vitamin C.
    ALEIXO J
    Hospital (Rio J); 1954 Oct; 46(4):377-82. PubMed ID: 14391853
    [No Abstract]   [Full Text] [Related]  

  • 30. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
    Norgren L; Hiatt WR; Dormandy JA; Nehler MR; Harris KA; Fowkes FG; ; Bell K; Caporusso J; Durand-Zaleski I; Komori K; Lammer J; Liapis C; Novo S; Razavi M; Robbs J; Schaper N; Shigematsu H; Sapoval M; White C; White J; Clement D; Creager M; Jaff M; Mohler E; Rutherford RB; Sheehan P; Sillesen H; Rosenfield K
    Eur J Vasc Endovasc Surg; 2007; 33 Suppl 1():S1-75. PubMed ID: 17140820
    [No Abstract]   [Full Text] [Related]  

  • 31. Information from your family doctor. Peripheral arterial disease.
    Am Fam Physician; 2004 Feb; 69(3):533. PubMed ID: 14971834
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral arterial disease (PAD). Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2009 Sep; 34(9):356. PubMed ID: 19664497
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of severe peripheral arterial occlusion.
    MONTGOMERY H
    Pa Med J; 1957 Jul; 60(7):831-4. PubMed ID: 13452699
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of peripheral arterial insufficiency].
    VERSTRAETE M
    Belg Tijdschr Geneesk; 1957 Aug; 13(19):972-8. PubMed ID: 13459858
    [No Abstract]   [Full Text] [Related]  

  • 35. Peripheral arterial insufficiency: evaluation as the basis of therapy.
    REEDY WJ
    Nebr State Med J; 1957 Nov; 42(11):527-9. PubMed ID: 13477284
    [No Abstract]   [Full Text] [Related]  

  • 36. Current therapeutic concepts of peripheral arterial disease.
    SAMUELS SS
    Int Rec Med; 1960 Oct; 173():626-31. PubMed ID: 13746021
    [No Abstract]   [Full Text] [Related]  

  • 37. The choice of treatment in peripheral arterial disease.
    HORWITZ O; BROOKE R
    GP; 1958 Apr; 17(4):127-36. PubMed ID: 13524361
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in peripheral arterial disease.
    MONTGOMERY H; HOLLING E
    Practitioner; 1958 Oct; 181(1084):446-52. PubMed ID: 13591159
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pain due to peripheral arterial circulation disorders & its conservative control].
    LINKE H
    Munch Med Wochenschr; 1957 Sep; 99(36):1293-8. PubMed ID: 13483478
    [No Abstract]   [Full Text] [Related]  

  • 40. Focus: intervention in peripheral arterial disease. Why every cardiologist should understand peripheral vascular issues.
    Walker CM
    J Invasive Cardiol; 2008 Sep; 20(9):A6, A8, A11. PubMed ID: 18798371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.